U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
HUMAN .BETA.-AMYLOID PEPTIDE (1-40)
13539D6GO8
Other
General
Record Details
Names
8
Identifiers
6
Subunits
1
Relationships
6
Characteristic Attributes
1
HUMAN .BETA.-AMYLOID PEPTIDE (1-40)
13539D6GO8
Other
General
Approval Year
Unknown
139,594
Record Details
Substance Class
Protein
Protein Sub Type
Sequence Type
COMPLETE
Record UNII
13539D6GO8
Record Status
Validated (UNII)
Record Version
13
12
11
10
9
8
7
6
5
4
3
2
1
Names
8
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
HUMAN .BETA.-AMYLOID PEPTIDE (1-40)
Common Name
English
A.BETA.40
Common Name
English
AMYLOID .BETA. PEPTIDE(1-40) (SYNTHETIC)
Common Name
English
ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL
Common Name
English
A.BETA.(1-40)
Common Name
English
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Identifiers
6
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
CHEBI
64646
PRIMARY
MERCK INDEX
m1878
PRIMARY
Merck Index
EPA CompTox
DTXSID50856170
PRIMARY
CAS
131438-79-4
PRIMARY
FDA UNII
13539D6GO8
PRIMARY
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Subunits
1
Subunit 0
>SUBUNIT_0
Relationships
6
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
11VWK61J69
CRISDESALAZINE
INHIBITOR -> TARGET
UH32L7RML6
LY-2599666
LIGAND->TARGET
Comments:
Targets soluble Aβ monomer to shift oligomer equilibrium and prevent direct neurotoxicity from soluble forms.
5D6PWO0333
SOLANEZUMAB
LIGAND->TARGET
Comments:
Designed to increase the clearance from the brain of soluble Aβ, peptides that may lead to toxic effects in the synapses and precede the deposition of fibrillary amyloid.
Amount:
O8AS5277H0
CRENEZUMAB
INHIBITOR -> TARGET
C35RF1MWQZ
ITANAPRACED
INHIBITOR OF RELEASE->TARGET
Amount:
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Characteristic Attributes
1
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
MOL_WEIGHT:SEQUENCE(CALCULATED)
CHEMICAL
SEQUENCE 4329.8 Da (average)
Showing 1 to 1 of 1 entries
Previous
1
Next
